Merrill Lynch Downgrades Monsanto Co. (MON) to Neutral
More News related to MON
- Pfizer Merger to Shut Down Six R&D Sites, Resulting in 2,000 Layoffs, an Industrial Info News Alert
- Monsanto Reconfirms 2010 Guidance and 2012 Financial Commitments on Strength of Larger Expected Launches for Blockbuster Products
- Monsanto (MON) Agrees to Acquire Pfizer's (PFE) Chesterfield Village Research Center for $435M
- Monsanto to Purchase Chesterfield Village Research Center From Pfizer
- Monsanto Breaks Ground on Lubbock Cotton Research Facility
More News related to Downgrades
- Standpoint Research Downgraded Deckers Outdoor (DECK) to Hold
- BGB Securities Downgrades Helmerich & Payne (HP) to Sell
- Sidoti & Co Downgrades Waste Services (WSII) to Neutral
- William Blair Downgrades Strayer (STRA), ITT (ESI) to Market Perform
- D.A. Davidson Downgrades Rocky Brands (RCKY) to Underperform
Merrill Lynch downgrades Monsanto Co. (NYSE: MON) from Buy to Neutral.
Monsanto Company, together with its subsidiaries, provides agricultural products for farmers principally in the United States.
Related Categories
DowngradesStocks Mentioned
+1.24Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
